By BY REBECCA ROBBINS from NYT The drug, from GlaxoSmithKline and Vir, aims to keep Covid patients out of the hospital.Business https://ift.tt/3yFK0IV
via
F.D.A. authorizes another antibody treatment for high-risk Covid patients.
By BY REBECCA ROBBINS from NYT The drug, from GlaxoSmithKline and Vir, aims to keep Covid patients out of the hospital.Business https://ift.tt/3yFK0IV
via
0 comments:
Post a Comment